Formulation and Evaluation of Pulsatile Drug Delivery System of Zafirlukast
In the current scenario of pharmaceutical research much attention has been focused on patients health in terms of therapeutic efficacy and economical standards (price factor).The formulation design consist of core tablets designed by direct compression method. Core tablets were coated with an naturally occurring swelling agent (carbopol & Karaya gum). Evaluation studies were performed for prepared pulsatile tablets hardness. In in vitro release profile of 6 hours study in first 5 hours it shows minimum drug release and at the end of six hours rapid and transient release was observed. Stability studies proved that coating of tablets seems to decrease the effect of temperature and moisture on degradation of Zafirlukast. The pulsatile release has been achieved from tablet over a 7-8 hour period.
2. Kilkuchi A and Okano T; "Pulsatile drug release control using hydrogels "; Advan. Drug Del. Reviews, 2002; 54:53-77.
3. Maurya SD, Arya RKK, Rajpal G, Dhakar RC, Self-micro emulsifying drug delivery systems (SMEDDS): a review on physico-chemical and biopharmaceutical aspects, Journal of Drug Delivery and Therapeutics 2017; 7(3):55-65
4. Okano T, Iskakov RM, Kikuchi A, Time-programmed pulsatile release of dextran from calciumalginate gel beads coated with carboxy-n-propylacrylamide copolymers. J. Controlled Release, 2002; 80:57–68.
5. Martin A, Physical Pharmacy-physiochemical principles in the pharmaceutical sciences. 4th Ed. New Delhi: B.I Waverly Pvt. Ltd; 1996; 313-31.
6. Liberman H, Lachman L. The Theory and Practice of Industrial Pharmacy. IIIrd ed.Bombay: Verghese Publication House; 1991; 171-193.
7. Momin A, Khan S, Ghadage DM, Yadav AV, Wagh A, Formulation and evaluation of bilayer tablets of propranolol hydrochloride, Journal of Drug Delivery and Therapeutics 2017; 7(2):50-57
8. Shivakumar HG, Pramod KTM, Kashappa GD. Pulsatile drug delivery systems.ssIndian J Pharm Educ. 2003 July-Sept; 37(3):125-128.
9. Robert W, Thomas P. Drug therapy for hypercholestemia and Dyslipidemia.In: Goodmen and Gilmans. The pharmacological basis of therapeutics.10th ed. 2003: McGraw- hill. Medical publishing division p. 971-972.
10. Patel KB, Vyas JR, Upadhyay UM, Formulation and evaluation of sustained release matrix tablets of nateglinide, ournal of Drug Delivery and Therapeutics 2015; 5(5):19-25
11. Gothaskar AV, Joshi AM, Joshi NH. Pulsatile drug delivery system-A review.DrugDel Tech. 2004 June; 4(5).
12. Anal AK. Time-Controlled Pulsatile Delivery Systems for Bioactive Compounds.Recent Patents on Drug Delivery & Formulation.2006 Dec; 1:73-79.vitro/in vivo evaluationReview. I J Pharm. 2002; 253:1-15.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).